Introduction {#S1}
============

A 60-year-old man presented to the emergency room with right eyelid ptosis, diplopia, and pain behind the right eye. Symptoms started 3 weeks ago with pain behind the right eye that was sharp and intermittent in nature, and each time lasting a few hours. He saw his ophthalmologist 1 week after symptom onset and was told to keep the eye moist with eye drops. However, the right retroocular pain gradually worsened and became 4/10 in intensity. During this time, he also developed right-sided ptosis and diplopia with associated nausea and vomiting.

His medical history was significant for diabetes mellitus, end stage renal disease status post combined pancreatic and renal transplant 8 years ago (on tacrolimus, prednisone, and mycophenolate), coronary artery disease and left shoulder Merkel cell carcinoma (MCC) (T2 N1 M0 stage IIIB) with metastasis to the left axilla that was resected 4 months prior to his presentation. At the time of his initial diagnosis of MCC, patient refused chemotherapy because of the risk of transplant rejection and he only received local radiotherapy. In terms of surgical history, he had right cataract surgery 1 year ago.

His family history was significant for father with a stroke and mother with hypertension and renal disease. He never smoked and drank three glasses of wine per week. He did not use illicit drugs. He was a retired laboratory technician at a particle board plant. His home medications included amlodipine, aspirin, carvedilol, cholecalciferol, cyanocobalamin, doxazosin, magnesium oxide, mycophenolate, tacrolimus, albuterol, amoxicillin, atorvastatin, cetirizine, clonidine, clopidogrel, furosemide, levothyroxine, lisinopril, mometasone, multiple vitamin, prednisone, and ranitidine.

On physical exam, vital signs were BP 122/63, pulse 65, respiratory rate 14, SpO~2~ 96%.

There was complete right-sided ptosis (he was unable to open it), with complete right eye ophthalmoplegia. The right pupil was dilated, 7 mm in size and fixed. Shining light to the right pupil constricted the left pupil. Left pupil was 3 mm in size and reactive to light, but shining light into the left pupil did not constrict the right pupil. The left eye had complete abduction paralysis (Figure [1](#F1){ref-type="fig"}; Video S1 in Supplementary Material). Visual acuity was 20/40 OD, 20/20 OS. Intraocular pressures were normal. Proptosis was not present. Dilated fundus exam showed temporal pallor of the disk in the right eye, and slight pallor of the disk in the left eye. Pinprick was mildly impaired in the right V1 and left V3 distributions. The rest of the neurological exam was unremarkable.

![Ptosis of the right eye and fixed and dilated right pupil.](fneur-08-00409-g001){#F1}

Brain MRI with contrast 4 months prior to his presentation did not reveal any abnormality. Differential diagnosis on admission included multiple cranial neuropathies secondary to Tolosa--Hunt syndrome, cavernous sinus thrombosis, infection, granulomatous process or neoplasm, especially in the setting of MCC. Brain MRI showed infiltrative, peripherally enhancing tumor centered within the clivus with soft tissue extension into the cavernous sinus (Figure [2](#F2){ref-type="fig"}). Brain MRV was performed without contrast due to concern for his transplanted kidney function and the cavernous sinus was not well visualized. CT of the chest showed left axillary and left low cervical lymphadenopathy but negative for lung masses. He was started on Dexamethasone 4 mg q6 hours to reduce tumor inflammation. Biopsy of the clival mass was performed with stereotactic, stealth CT-guided bilateral endoscopic sphenoidotomy and partial ethmoidectomy. The posterior vomer and intersinus septum were removed within the sphenoid and biopsies were taken from the sphenoid mass seen along the floor. H&E slides of the biopsy showed a small round blue cell tumor. Immunuohistochemical slides showed the tumor was positive for CD56, cytokeratin CAM 5.2 (perinuclear dot-like pattern), and cytokeratin 20 (perinuclear dot-like pattern). The tumor was negative for TTF-1, leukocyte common antigen (LCA), S-100, and melan-A (Figure [3](#F3){ref-type="fig"}). These findings were consistent with metastatic MCC. Further culture revealed colonization with Scopulariopsis species for which he was started on Posaconazole. He was started on palliative radiation therapy and he declined chemotherapy. Repeat MRI in 1 month and CT scan 2 months later did not reveal progression of the clival metastasis, but new metastatic lesions were found in the cervical spine involving C2, C3, C5, and C6 vertebral bodies. He was put on a cervical collar, but no further surgical or radiation therapy was performed as the patient was asymptomatic. Hospice was considered but the patient declined due to the need to stop his antirejection medications. At the time of submission of this manuscript, 6 months after the initial discovery of the Merkel cell metastasis to the clivus, the patient remained alive.

![MRI brain with contrast showing Merkel cell carcinoma (MCC) metastasis to the clivus and invasion into the cavernous sinus. **(A)** Transverse view. Arrow is pointing to the mass in the clivus. **(B)** Sagittal view. Arrow is pointing to the mass in the clivus. **(C)** Coronal view. **(D)** Magnified view of the cavernous sinus from **(C)**. There is invasion of the metastatic MCC into the cavernous sinus with likely impingement on the cranial nerves.](fneur-08-00409-g002){#F2}

![Histological and immunophenotypical features of the clival mass. **(A)** H&E stain at 20× showing small round blue cells. **(B)** CD56 stain positive. **(C)** Cytokeratin CAM 5.2 stain positive. **(D)** Magnified view of the cytokeratin CAM 5.2 stain showing perinuclear dot-like pattern.](fneur-08-00409-g003){#F3}

Background {#S2}
==========

Merkel cell carcinoma is a rare but aggressive cutaneous neuroendocrine tumor. Our case is unique in that the patient presented with right III, IV, V1, VI and left V3, VI cranial nerve palsies without proptosis, mimicking Tolosa--Hunt syndrome or bilateral cavernous sinus thrombosis. This is the first case showing distant MCC metastasis to the clivus with invasion of the cavernous sinuses. His presentation with complete right ptosis, fixed and dilated pupil along with impairment of all extraocular movement of the right eye is unique. The only case report of metastatic MCC involving the cavernous sinus was by Chang et al. ([@B1]). However, that case presented only with retro-orbital pain and hemifacial, hemi-tongue numbness. In addition, the primary site of the MCC was on the face 2 years prior to his presentation, with subsequent perineural spread to the brain and leptomeningeal dissemination.

Clivus is a part of the cranium at the skull base sitting adjacent to the sphenoid sinuses and cavernous sinuses. The abducens nerves tracks along the clivus and a tumor within the clival space can often cause abducens nerve palsies ([@B2]). This patient presented with bilateral abducens nerve palsy, which is compatible with the clival metastasis. The infiltration into the cavernous sinuses caused right CN III, IV, V1. The left V3 nerve can be secondary to the clival mass or to extension of the cavernous sinus tumor infiltration since V3 is located adjacent to both structures (Figure [2](#F2){ref-type="fig"}D).

Merkel cell carcinoma brain metastases typically occur after a mean period of 19.7 months ([@B3]). The patient presented here was diagnosed and treated for MCC just 4 months prior to his presentation. The growth of his MCC metastasis was also rapid. Brain MRI with contrast 3 months prior to his ocular symptoms did not show any sign of metastasis. He progressed rapidly within 3 weeks of symptom onset and his clinical picture was not concerning enough for an ophthalmologist who examined him 2 weeks prior to his presentation.

Our literature review revealed a total of 40 cases of MCC metastasis to the central nervous system (Table [1](#T1){ref-type="table"}). The average age at the time of metastasis is 63.66 years old with 60% of the cases being male. 97% of the cases (39 out of 40 cases) had metastasis to the brain or leptomeninges, with the only exception being the report by Chang et al. with perineural spread to the bilateral acoustic meatus and trigeminal cistern ([@B1]). The average time for CNS spread after the primary diagnosis is 24.77 months. The survival rate after the CNS diagnosis is 73% at 6 months and 33% at 1 year. This is consistent with the previous report of a median survival time of 8.5 months after a diagnosis of Merkel cell CNS metastasis ([@B4]). None of the reported cases described prior immunosuppression before MCC was detected. The reported case here was diagnosed at age of 60, 4 months after the diagnosis of the primary tumor. He had multiple comorbidities including multiorgan transplant status which, along with metastatic MCC, indicate a poor prognosis.

###### 

Literature review of central nervous system metastasis of Merkel cell carcinoma.

  Case                             Age/sex                   Primary lesion                                 Location of metastasis                                        Time to CNS disease after primary Dx   Survival after CNS metastasis   Immunosuppression before primary lesion
  -------------------------------- ------------------------- ---------------------------------------------- ------------------------------------------------------------- -------------------------------------- ------------------------------- -----------------------------------------
  Kroll et al. ([@B5])             48M                       NA                                             Brain                                                         NA                                     NA                              None
  Kroll et al. ([@B5])             70M                       NA                                             Brain                                                         NA                                     NA                              None
  Kroll et al. ([@B5])             72F                       NA                                             Meninges                                                      NA                                     NA                              None
  Wick et al. ([@B6])              62M                       Face                                           Brain                                                         12 months                              1 month                         None
  Wick et al. ([@B6])              76M                       Right retroauricular area                      Brain                                                         3 years                                0 month                         None
  Goepfert et al. ([@B7])          NA                        NA                                             Brain                                                         NA                                     NA                              None
  Giannone et al. ([@B8])          57F                       Scalp                                          Right frontoparietal                                          2 months                               4 months, survived              None
  Grosh et al. ([@B9])             57F                       NA                                             Brain                                                         2 months                               12 months                       None
  Grosh et al. ([@B9])             56M                       NA                                             Brain                                                         ≥21 months                             NA                              None
  Hitchcock et al. ([@B10])        52M                       Left breast                                    Brain                                                         3 months                               9 months                        None
  Knox et al. ([@B11])             75F                       Right neck                                     Left cerebellum                                               4 years                                NA                              None
  Knox et al. ([@B11])             60M                       Inguinal nodes                                 Leptomeninges                                                 10 months                              14 months                       None
  Dudley et al. ([@B12])           64M                       NA                                             Leptomeninges                                                 17 months                              6 days                          None
  Alexander et al. ([@B13])        56M                       Left face                                      Right parietal                                                Present at dx                          3 years                         None
  Wojak and Murali ([@B14])        78F                       NA                                             Calvaria, Dura                                                Present at dx                          ≥1 year                         None
  Manome et al. ([@B15])           57F                       NA                                             Frontal skull base, brain                                     Present at dx                          NA                              None
  Small et al. ([@B16])            56M                       NA                                             Brain                                                         Present at dx                          22 months                       None
  Yiengpruksawan et al. ([@B17])   NA                        NA                                             Brain                                                         NA                                     NA                              None
  Sharma et al. ([@B18])           57M                                                                      Brain                                                         Present at dx                          13 months                       None
  Snodgrass et al. ([@B19])        61M                       Forehead                                       Right parietal, leptomeninges                                 1 year                                 6 months                        None
  Eftekhari et al. ([@B20])        NA                        NA                                             Brain                                                         NA                                     NA                              None
  Eftekhari et al. ([@B20])        NA                        NA                                             Brain                                                         NA                                     NA                              None
  Eftekhari et al. ([@B20])        NA                        NA                                             Brain                                                         NA                                     NA                              None
  Matula et al. ([@B21])           47M                       NA                                             Anterior skull base, dura, brain                              Present at dx                          12 months                       None
  Straka et al. ([@B22])           71F                       NA                                             Brain                                                         10 months                              2 months                        None
  Litofsky et al. ([@B23])         86F                       External auditory canal                        Brain                                                         16 months                              ≥8 months                       None
  Ikawa et al. ([@B24])            48F                       Left elbow                                     Right cerebellum                                              5 years                                11 months                       None
  Eggers et al. ([@B25])           69M                       NA                                             Pons and midbrain, leptomeninges                              17 months                              \<2 months                      None
  Barkdull et al. ([@B26])         55M                       Scalp                                          Calvaria, Dura                                                Present at dx                          10 months                       None
  Faye et al. ([@B27])             85M                       NA                                             Right parietal                                                1 year                                 NA                              None
  Faye et al. ([@B27])             68M                       NA                                             Brain, leptomeninges                                          1 year                                 7 months                        None
  Chang et al. ([@B1])             45M                       Left temporal skin                             Bilateral internal acoustic meatus, left trigeminal cistern   2 years                                ≥3 months                       None
  De Cicco et al. ([@B28])         69M                       NA                                             Brain                                                         22 months                              6 months                        None
  Feletti et al. ([@B3])           65F                       NA                                             Pituitary                                                     3.5 years                              ≥8 months                       None
  Bailey et al. ([@B4])            75F                       Nasal ala                                      Right parietal                                                1 year                                 7 months                        None
  Bailey et al. ([@B4])            77F                       Left scalp                                     Parietal lobe, scalp                                          Present at dx                          ≥16 months                      None
  Bailey et al. ([@B4])            51F                       Right calf/inguinal lymph nodes                Right temporal lobe                                           4 years                                \>21 months, survived           None
  Abul-Kasim et al. ([@B29])       65M                       Left inguinal, iliac, aortocaval lymph nodes   Right parietal, lumbar spine                                  NA                                     8 months, survived              None
  Seaman et al. ([@B30])           78M                       Right groin                                    Left central pontine angle mass                               2 months                               5 months, survived              None
  This report                      60M                       Left shoulder                                  Clivus, cavernous sinus                                       4 months                               --                              Yes
  Average                          63.66 years old           --                                             --                                                            24.76 ± 19.5 months                    6 months survival: 73%          
  60% M                            12 months survival: 33%                                                                                                                                                                                       

Discussion {#S3}
==========

When the patient first presented, Tolosa--Hunt syndrome and cavernous sinus thrombosis were the top two differential diagnoses. However, cavernous sinus thrombosis typically presents with proptosis (80--100%) ([@B31]), and our patient did not, making Tolosa--Hunt syndrome a more compelling etiology on presentation. Tolosa--Hunt syndrome is an idiopathic, sterile inflammation affecting the cavernous sinus. It is defined by the International Headache Society as "episodic orbital pain associated with paralysis of one or more of the third, fourth, and/or sixth cranial nerves, which usually resolves spontaneously but tends to relapse and remit" ([@B32]). Tolosa--Hunt syndrome is typically unilateral, with bilateral symptoms occurring in only about 4% of the cases ([@B33]). Cranial nerve III is the most commonly affected cranial nerve (78.3%), followed by cranial nerve VI (41.3%), cranial nerve IV (30.4%), the ophthalmic branch of cranial nerve V (28.1%), and cranial nerve II (10.9%). Multiple nerves may be affected simultaneously in 54.3% of patients ([@B33]). The maxillary and mandibular divisions of the fifth nerve and even facial nerve may be affected ([@B34], [@B35]). Abnormal MRI findings occurr in only 52% of the patients ([@B33]). The patient presented here had involvement of the right cranial nerve III, IV, VI, and ophthalmic branch of V, as well as left cranial nerve VI and mandibular division of V. There was orbital pain behind the right eye. Other than the prolonged duration (3 weeks), the clinical picture would fit Tolosa--Hunt syndrome. MCC metastasis did not become the top differential diagnosis until MRI brain was obtained.

The patient was immunocompromised due to the use of immunosuppressants for his renal and pancreatic transplants. Immunosuppression is a significant risk factor, as the risk of developing MCC significantly increases with human immunodeficiency virus ([@B36], [@B37]), and chronic lymphocytic leukemia ([@B38], [@B39]). Solid organ transplant status has also been shown to increase the risk of developing MCC by 23.8-fold ([@B40]). In the study by Clarke et al., the incidence of MCC in renal transplant was 13.8 per 100,000 person-year, which translates to 25.7-fold increase in risk of developing MCC compared to the general population. In another study, the standardized incidence ratio of MCC is as high as 66 for patients with renal transplant ([@B41]). In that study, three cases of MCC were detected among 4,200 individuals who underwent renal transplantation. All three identified cases were on immunosuppressive medications. The latency between transplant and MCC ranged from 6 to 19 years. All three cases died and the survival time between diagnosis of MCC and death ranged from 0.5 to 2.1 years. Our patient had both renal and pancreatic transplant, which likely increased his risk of developing MCC. He developed MCC 8 years after his renal and pancreatic transplant, which is in line with the reported latency.

Merkel cell polyoma virus was detected in about 80% of all MCCs ([@B42]). Because immunosuppression has been shown to be a significant risk factor, it has been hypothesized that immunosuppression after an organ transplant increases the risk of Merkel cell polyoma virus infection and thus increases the risk of developing MCC. However, the study by Koljonen et al. ([@B41]) showed that only one out of the three MCC cases with renal transplant status (33%) was tested positive for Merkel cell polyoma virus. This rate was lower than the 80% expected in the general population. Even though these data argue against the hypothesis of polyoma virus being the underlying cause of MCC in organ transplant patients, the sample size is currently too small to draw a conclusion. Unfortunately, in the case presented here, we do not have the Merkel cell polyoma virus data available.

Concluding Remarks {#S4}
==================

This case is unique because it is the only case report showing MCC metastasis to the clivus from a distant site. It also demonstrates that MCC metastasis symptoms can progress rapidly within weeks and can masquerade as symptoms of Tolosa--Hunt syndrome or cavernous sinus thrombosis.
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